Risk factors and pathogenesis of Hashimoto's thyroiditis;Hašimoto tiroidito rizikos veiksniai ir patogenezė

Medicina

Volumn 45, Issue 7, 2009, Pages 574-583

  Paknys, Gintaras ^a   Kondrotas, Anatolijus Juozas ^a   Kevelaitis, Egidijus ^a  

^a Kardiologijos institutas   (Lithuania)

Author keywords

Autoimmune thyroid disease; T cells; Thyroid antigens

Indexed keywords

ANTIBODY; AUTOANTIBODY; THYROGLOBULIN;

ADULT; ANIMAL; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; DISEASE MODEL; FEMALE; GENETIC PREDISPOSITION; GENETICS; HASHIMOTO DISEASE; HUMAN; HUMORAL IMMUNITY; IMMUNOLOGY; MALE; MIDDLE AGED; MOUSE; PREGNANCY; RABBIT; RAT; REVIEW; RISK FACTOR; SEX DIFFERENCE; T LYMPHOCYTE; THYROID GLAND;

ADULT; ANIMALS; ANTIBODIES; AUTOANTIBODIES; DISEASE MODELS, ANIMAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HASHIMOTO DISEASE; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; MALE; MICE; MIDDLE AGED; PREGNANCY; RABBITS; RATS; RISK FACTORS; SEX FACTORS; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC; THYROGLOBULIN; THYROID GLAND;

EID: 70349400383     PISSN: 1010660X     EISSN: None     Source Type: Journal    
DOI: 10.3390/medicina45070076     Document Type: Review

References (45)

1. Salvi M, Fukazawa H, Bernard N. Role of autoantibodies in the pathogenesis and association of endocrine autoimmune disorders. Endocr Rev 1988;9:450-66.
2. Chiovato L, Latrofa F, Braverman LE, Pacini F, Capezzone M, Masserini L, et al. Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens. Ann Intern Med 2003;139:346-51.
3. Bell PM, Sinnamon DG, Smyth PPA. Hyperthyroidism following primary hypothyroidism in association with polyendocrine autoimmunity. Acta Endocrinol (Copenh) 1996;108: 491-7.
4. Paknys G, Kondrotas AJ, Kėvelaitis E. Cukrinis diabetas ir la{ogonek}stelinis imunitetas. (Diabetes mellitus and cellular immunity.) Medicina (Kaunas) 2006;42(1):1-8.
5. Urbonienė D, Sakalauskas R, Šitkauskienė B. Autoimuninio mechanizmo reikšmė lėtinės obstrukcinės plaučiu{ogonek} ligos patogenezei. (Autoimmunity in pathogenesis of chronic obstructive pulmonary disease.) Medicina (Kaunas) 2005;41(3): 190-4.
6. Weigle WO, Nakamura RM. The development of autoimmune thyroiditis in rabbits following injection of aqueous preparations of heterologous thyroglobulins. J Immunol 1967;99: 223.
7. Taguchi O, Takahashi T. Mouse models of autoimmune disease suggest that self-tolerance is maintained by unresponsive autoreactive T cells. Immunology 1996;89:13-9.
8. Verginis P, Li HS, Carayanniotis G. Tolerogenic semimature dendritic cells suppress experimental autoimmune thyroiditis by activation of thyroglobulin-specific CD4+, CD25+ T cells. J Immunol 2005;174:7433-9.
9. Ng HP, Banga JP, Kung AWC. Development of a murine model of autoimmune thyroiditis induced with homologous mouse thyroid peroxidase. Endocrinology 2004;145:809-16.
10. Flynn JC, Meroueh C, Snower DP, David CS, Kong YM. Depletion of CD4+CD25+ regulatory T cells exacerbates sodium iodide-induced experimental autoimmune thyroiditis in human leucocyte antigen DR3 (DRB1*0301) transgenic class II-knock-out non-obese diabetic mice. Clin Exp Immunol 2007;147:547-54.
11. Li HS, Verginis P, Carayanniotis G. Maturation of dendritic cells by necrotic thyrocytes facilitates induction of experimental autoimmune thyroiditis. Clin Exp Immunol 2006; 144:467-74.
12. Dai YD, Rao VP, Carayanniois G. Enhanced iodination of thyroglobulin facilitates processing and presentation of a cryptic pathogenic peptide. J Immunol 2002;168:5907-11.
13. Tamai H, Uno H, Hirota Y. Immunogenetics of Hashimoto's and Graves diseases. J Clin Endocrinol Metab 1985;60:62-6.
14. Pearce EN, Farwell AP, Braverman LE. Thyroiditis. N Engl J Med 2003;348:2646.
15. Kosugi S, Ban T, Akamizu T, Kohn LD. Identification of separate determinants on the thyrotropin receptor reactive with Graves' thyroid-stimulating antibodies and with thyroidstimulating blocking antibodies in idiopathic myxedema: these determinants have no homologous sequence on gonadotropin receptors. Molecul Endocrinol 1992;6:168-80.
16. Kawakami Y, Fisfalen M-E, DeGroot LJ. Proliferative responses of peripheral blood mononuclear cells from patients with autoimmune thyroid disease to synthetic peptide epitopes of human thyroid peroxidase. Autoimmunity 1992;13:17-26.
17. Ng HP, Kung AW. Induction of autoimmune thyroiditis and hypothyroidism by immunization of immunoactive T cell epitope of thyroid peroxidase. Endocrinology 2006;147(6): 3085-92.
18. Itoh M, Takahashi T, Sakaguchi N, Kuniyasu Y, Shimizu J, Otsuka F, et al. Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic selftolerance. J Immunol 1999;162:5317-26.
19. Phelps E, Wu P, Bretz J, Baker JR Jr. Thyroid cell apoptosis: a new understanding of thyroid autoimmunity. Endocrinol Metab Clin North Am 2000;29:375-88.
20. Stassi G, Di Liberto D, Todaro M. Control of target cell survival in thyroid autoimmunity by T helper cytokines via regulation of apoptotic proteins. Nat Immunol 2000;1:483-8.
21. Stassi G, Todaro M, Bucchieri F, Stoppacciaro A, Farina F, Zummo G, et al. Fas/Fas ligand-driven T cell apoptosis as a consequence of ineffective thyroid immunoprivilege in Hashimoto's thyroiditis. J Immunol 1999;162:263-7.
22. Mitsiiades N, Poulaki V, Kotoula V, Mastorakos G, Balafouta S, Koutras DA, et al. Fas/Fas ligand up-regulation and BCL-2 down-regulation may be significant in the pathogenesis of Hashimoto' thyroiditis. J Clin Endo Metab 1998;83:2199.
23. Kawakami A, Eguchi K, Matsuoka N, Tsuboi M, Kawabe Y, Ishikawa N, et al. Thyroid-stimulating hormone inhibits Fas antigen-mediated apoptosis of human thyrocytes in vitro. Endocrinology 1996;137:3163.
24. Batteux F, Lores P, Bucchini D, Chiocchia G. Transgenic expression of Fas ligand on thyroid follicular cells prevents autoimmune thyroiditis. J Immunol 2000;164:1681-8.
25. Li YS, Kanamoto N, Hataya Y, Moriyama K, Hiratani H, Nakao, et al. Transgenic mice producing major histocompatibility complex class II molecules on thyroid cells do not develop apparent thyroid autoimmunity. J Clin Endocrinol Metab 2004;145: 2524-30.
26. Marelli-Berg F, Weetman AP, Frasca L, Deacock SJ, Inami N, Lombardi G, et al. Antigen presentation by epithelial cells induces anergic immunoregulatory CD45RO+ T cells and deletion of CD45RA+ T cells. J Immunol 1997;159:5853-61.
27. Stassi G, DeMaria R. Autoimmune thyroid disease: new models of cell death in autoimmunity. Nat Rev Immunol 2002;2:195-204.
28. Kotani T, Aratake Y, Hirai K, Fukazawa Y, Sato H, Ohtaki S. Apoptosis in thyroid tissue from patients with Hashimoto's thyroiditis. Autoimmunity 1995;20:231.
29. Brix TH, Kyvik KO, Hegedus L. A population-based study of chronic autoimmune hypothyroidism in Danish twins. J Clin Endocr Metab 2000;85:536-9.
30. Barbesino G, Chiovato L. The genetics of Hashimoto's disease. Endocrinol Metal Clin North Am 2000;29(2):357-74.
31. Tomer Y. Common and unique susceptibility loci in Graves' and Hashimoto's diseases: results of whole - genome screening in a data set of 102 multiplex families. Am J Hum Genet 2003;73(4):736-47.
32. Tomer Y, Greenberg DA, Barbesino G. CTLA-4 and not CD28 is a susceptibility gene for thyroid autoantibody production. J Clin Endocrinol Metab 2001;86:1687-93.
33. Brix TH, Knudsen GPS, Kristiansen M, Kyvik KO, Orstavik KH, Hegedus L. High frequency of skewed X-inactivation in females with autoimmune thyroid disease: a possible explanation for female predisposition to thyroid autoimmunity. J Clin Endocrinol Metab 2005;90:5949-53.
34. Stagnaro-Green A. Recognizing, understanding, and treating postpartum thyroiditis. Endocrinol Metab Clin North Am 2000;29:417-30.
35. Lambert NC, Evans PC, Hashizumi TL. Cutting edge: persistent fetal microchimerism in T lymphocytes is associated with HLA-DQA1*0501: implications in autoimmunity. J Immunol 2000;164:5545-8.
36. Imaizumi M, Pritsker A, Unger P, Davies TF. Intrathyroidal fetal microchimerism in pregnancy and postpartum. Endocrinology 2002;143:247-53.
37. Bulow Pedersen I, Laurberg P, Knudsen N, Jorgensen T, Perrild H, Ovesen L, et al. Lack of association between thyroid autoantibodies and parity in a population study argues against microchimerism as a trigger of thyroid autoimmunity. Eur J Endocrinol 2006;154:39-45.
38. Nagata K, Takasu N, Akamine H, Ohshiro C, Komiya I, Murakami K, et al. Urinary iodine and thyroid antibodies in Okinawa, Yamgata, Hyogo, and Nagano, Japan: the differences in iodine intake do not affect thyroid antibody positivity. Endoc J 1998;45:797-803.
39. Ruwhof C, Drexhage HA. Iodine and thyroid autoimmune disease in animal models. Thyroid 2001;11:427-36.
40. Atkins MB, Mier JW, Parkinson DR, Gould JA, Berkman EM, Kaplan MM. Hypothyroidism after treatment with interleukin-2 and lymphokine-activated killer cells. N Engl J Med 1988;318:1557-63.
41. Carella C, Mazziotti G, Amato G, Braverman LE, Roti E. Interferon-α-related thyroid disease: pathophysiological, epidemiological and clinical aspects. J Clin Endocrinol Metab 2004;89:3656-61.
42. Vermiglio F, Castagna MG, Volnova E, Lo Presti VP, Moleti M, Violi MA, et al. Post-Chernobyl increased prevalence of humoral thyroid autoimmunity in children and adolescents from a moderately iodine-deficient area in Russia. Thyroid 1999;9:781-6.
43. Volzke H, Werner A, Wallaschofski H. Occupational exposure to ionizing radiation is associated with autoimmune thyroid disease. J Clin Endocrinol Metab 2005;90:4587-92.
44. Bonar BD, McColgan B, Smith DF. Hypothyroidism and aging: the Rosses' survey. Thyroid 2000; 10:821-827.
45. Tomer Y, Davies TF. Infection, thyroid disease, and autoimmunity. Endocrine Rev 1993;14:107-20.